TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2016

Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.

Gary A Ulaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.